๐ฐ Binding Affinity News
Page 12 - Binding Affinity News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Binding Affinity. Real-time updates on events, politics, business and more.
December 29, 2021
Researchers from the University of Colorado Anschutz Medical Campus have been investigating the changes imparted on the Gamma variant by three RBD mutations.
December 29, 2021
Now in new research, scientists from the University of Leicester have been investigating how these mutations alter the affinities of RBDs to ACE2.
December 22, 2021
A team of scientists from Canada has recently characterized a panel of nanobodies against the spike protein of SARS-CoV-2.
December 22, 2021
New study results highlight that Omicron has an increased affinity to ACE-2 receptors, therefore, has increased infectivity, viral load, and transmissibility compared to other variants of concern, including the Delta variant.
December 20, 2021
A new study highlights the potential evolutionary trade-off observed in the omicron variant, detailing the dynamics of the protein structure, its interactions, and subsequent effects.
December 17, 2021
Researchers investigated the mutations reported in the Omicron variant and its likely impact on the use of therapeutic antibodies in COVID-19 treatment as well as on vaccinated individuals.
December 15, 2021
Researchers compared the binding of the new SARS-CoV-2 VOC Omicronโs RBD and ACE2 receptor with the original Wuhan SARS-CoV-2 strain and other VOCs such as Beta and Delta.
December 13, 2021
In a recent study, ten human PDZ-containing proteins showed significant interactions with the SARS-CoV-2 E protein in a PBM-dependent manner.
December 9, 2021
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), since its emergence, has continuously evolved to evade host hostilities as well as increase transmission by raising new variants of...
December 8, 2021
Researchers investigate the conformational dynamics of the SARS-CoV-2 RBD using the atomistic molecular dynamics simulation method.